Healthy Extracts (HYEX) Non-Current Debt (2016 - 2020)

Healthy Extracts (HYEX) posted quarterly Non-Current Debt of $866.0 for Q3 2020, little changed quarter-over-quarter from $866.0 in Q2 2020.

Healthy Extracts (HYEX) Non-Current Debt (2016 - 2020) Analysis & Trends

Healthy Extracts' Non-Current Debt history runs 4 years deep, the most recent figure standing at $866.0 for Q3 2020.

In Q3 2020, Non-Current Debt changed N/A year-over-year to $866.0; the TTM figure through Sep 2020 stood at $866.0 (changed N/A YoY), while the FY2019 annual figure was $1.0 million, up 1566.67% from the prior year.
Non-Current Debt for Q3 2020 stood at $866.0, roughly flat from $866.0 in the prior quarter.
The five-year high for Non-Current Debt was $1.1 million in Q1 2020, with the low at $866.0 in Q2 2020.
The 4-year median for Non-Current Debt is $37898.5 (2016), against an average of $376393.7.
Peak annual rise in Non-Current Debt reached 1566.67% in 2019, while the deepest fall reached 1566.67% in 2019.
Healthy Extracts' Non-Current Debt stood at $12797.0 in 2016, then surged by 392.3% to $63000.0 in 2018, then surged by 1566.67% to $1.0 million in 2019, then sank by 99.92% to $866.0 in 2020.
Business Quant data shows HYEX's Non-Current Debt at $866.0 in Q3 2020, $866.0 in Q2 2020, and $1.1 million in Q1 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Non-Current Debt (Qtr)
1	Haleon	43.83 Bn	42.86 Bn	-	-8.44 Bn
2	Teva Pharmaceutical Industries	42.87 Bn	39.22 Bn	2.15 Bn	12.09 Bn
3	Zoetis	31.41 Bn	29.73 Bn	1.05 Bn	9.05 Bn
4	Takeda Pharmaceutical	28.55 Bn	22.75 Bn	5.10 Bn	27.73 Bn
5	United Therapeutics	22.08 Bn	19.42 Bn	683.80 Mn	-
6	Viatris	18.73 Bn	17.84 Bn	1.46 Bn	11.61 Bn
7	Neurocrine Biosciences	15.44 Bn	15.05 Bn	935.80 Mn	-
8	Elanco Animal Health	11.75 Bn	11.22 Bn	798.00 Mn	3.85 Bn
9	Dr Reddys Laboratories	10.11 Bn	9.94 Bn	-	130.00 Mn
10	Healthy Extracts	19.90 Mn	19.71 Mn	1.45 Mn	-

Download Data